QUINTA-ANALYTICA have been approved for registration into the Ministère de l’Enseignement Supérieur et de la Recherche (France) Tax Credit system (CIR).

As a European based pharmaceutical company, Quinta are proud to have been granted approval into the French Tax Credit system for at least the next two years, opening the door for our French partners to take advantage of the R&D tax credit benefits offered by the Ministry of Research and Innovation.

The CIR is a public aid which supports the efforts of companies conducting Research and Development (fundamental research, applied research, experimental development) and also Innovation (expenditure for the production of prototypes or installations of new product pilots) via tax credit relief.

If you operate in France and are looking for a EU based partner who can deliver world class service and testing, get in touch to learn more about the tax incentives available to you and how you can offset your investment in research against your corporation tax bill.

Additional News

  • 18 March 2024

    News from our newly opened clinic in Ostrava

    Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.